Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Daneman

Showing results (221-230 of 361) with videos related to

Pageof 37
Sort By:
BMJ Open|June 27, 2023
Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trialBenjamin A Rogers, Robert Fowler, Patrick N A Harris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2026
Hierarchical composite endpoints provide a flexible framework to ensure clinical trials measure outcomes important to all stakeholdersSean W X Ong, Robert K Mahar, Chris J Selman, et al.
Plos One|March 4, 2017
A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissionsNatasha Nanwa, Beate Sander, Murray Krahn, et al.
Infection Control and Hospital Epidemiology|May 5, 2022
The utility of routine autologous bone-flap swab cultures in predicting post-cranioplasty infectionTuan Hoang, Nick Daneman, Jerome A Leis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2025
Making sense of hierarchical composite endpoints in randomized clinical trials - a primer for infectious disease clinicians and researchersSean W X Ong, Robert K Mahar, Chris J Selman, et al.
JAMA Ophthalmology|February 23, 2013
Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injectionVivian T Yin, Daniel J Weisbrod, Kenneth T Eng, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Development of a provincial interactive antibiogram tool for OntarioJennifer Lo, Bradley J Langford, Valerie Leung, et al.
Open Forum Infectious Diseases|June 24, 2026
Application of a Novel Desirability of Outcome Ranking Endpoint Incorporating a Framework for Resistance Assessment and Microbiologic Evaluation in Antibiotic Trials: A Proof-of-Concept in a Post Hoc Analysis of the BALANCE TrialSean W X Ong, Aditi Patrikar, Ruxandra Pinto, et al.
Jac-Antimicrobial Resistance|May 1, 2026
Antimicrobial stewardship resourcing and programme outcomes: a scoping reviewBradley J Langford, Amy Y Kang, Michelle Ji, et al.
Eclinicalmedicine|October 16, 2023
Antibiotic prescribing guideline recommendations in COVID-19: a systematic surveyBradley J Langford, Valerie Leung, Jennifer Lo, et al.
Pageof 37

Showing results (221-230 of 361) with videos related to

Sort By:
Pageof 37
BMJ Open|June 27, 2023
Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trialBenjamin A Rogers, Robert Fowler, Patrick N A Harris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2026
Hierarchical composite endpoints provide a flexible framework to ensure clinical trials measure outcomes important to all stakeholdersSean W X Ong, Robert K Mahar, Chris J Selman, et al.
Plos One|March 4, 2017
A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissionsNatasha Nanwa, Beate Sander, Murray Krahn, et al.
Infection Control and Hospital Epidemiology|May 5, 2022
The utility of routine autologous bone-flap swab cultures in predicting post-cranioplasty infectionTuan Hoang, Nick Daneman, Jerome A Leis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2025
Making sense of hierarchical composite endpoints in randomized clinical trials - a primer for infectious disease clinicians and researchersSean W X Ong, Robert K Mahar, Chris J Selman, et al.
JAMA Ophthalmology|February 23, 2013
Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injectionVivian T Yin, Daniel J Weisbrod, Kenneth T Eng, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Development of a provincial interactive antibiogram tool for OntarioJennifer Lo, Bradley J Langford, Valerie Leung, et al.
Open Forum Infectious Diseases|June 24, 2026
Application of a Novel Desirability of Outcome Ranking Endpoint Incorporating a Framework for Resistance Assessment and Microbiologic Evaluation in Antibiotic Trials: A Proof-of-Concept in a Post Hoc Analysis of the BALANCE TrialSean W X Ong, Aditi Patrikar, Ruxandra Pinto, et al.
Jac-Antimicrobial Resistance|May 1, 2026
Antimicrobial stewardship resourcing and programme outcomes: a scoping reviewBradley J Langford, Amy Y Kang, Michelle Ji, et al.
Eclinicalmedicine|October 16, 2023
Antibiotic prescribing guideline recommendations in COVID-19: a systematic surveyBradley J Langford, Valerie Leung, Jennifer Lo, et al.
Pageof 37